Last reviewed · How we verify

NCT07240870

Age-dependent EEG Characteristics During Desflurane Anesthesia From Adults to Elderlies

Completed Last updated 21 November 2025
What this trial tests

trial testing Age in EEG in 47 participants. Completed in 30 June 2025.

Timeline
24 April 2025
Primary endpoint
30 June 2025
30 June 2025

Quick facts

Lead sponsorChinese PLA General Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment47
Start date24 April 2025
Primary completion30 June 2025
Estimated completion30 June 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Chinese PLA General Hospital

Who can join

18 and older, any sex, with EEG or Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a prospective cohort study that records bilateral frontal EEG data from patients undergoing elective non-cardiac or non-neurosurgical surgeries and divides them into different age groups based on age. All patients received maintenance of general anesthesia with desflurane, and the periodic and aperiodic components, permutation cross mutual information (PCMI), and phase lag entropy (PLE) of EEG data were analyzed under different states of wakefulness, general anesthesia, and recovery. Professional correlation analysis methods were used to analyze the EEG spectrum.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Age

Trials testing the same drug.

Other recruiting trials for EEG

Currently open trials in the same condition.

Other Chinese PLA General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07240870.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing